RAP 0.00% 20.5¢ raptor resources limited

Math problem with results, page-214

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 341 Posts.
    lightbulb Created with Sketch. 911
    Not sure if the confidence intervals for the Australian Paediatric study have been calculated and posted by anyone yet. I know a few holders were interested, and Tony mentioned them in the CC. The calculations can be worked using data in the ASX release. Unsure why they weren't included in the original release.
    Cheers n1
    DYOR/GLTAH

    Australian Paediatric Study Results - 22 June 2017
    Pneumonia (123 patients)
    (cough, age, gender and symptoms)
    PPA 89% (95%CI 82%-94%)
    NPA 94% (95%CI 71%-86%)

    Croup (57 patients)
    (cough, age, gender and symptoms)
    PPA 100% (95%CI 94%-100%)
    NPA 96% (95%CI 88%-100%)

    Primary Upper Respiratory Tract Infection (53 patients)
    (cough, age, gender and symptoms)
    PPA 92% (95%CI 82%-98%)
    NPA 89% (95%CI 77%-96%)

    Bronchiolitis (101 patients)
    (cough, age, gender and symptoms)
    PPA 95% (95%CI 89%-98%)
    NPA 94% (95%CI 88%-98%)

    Asthma/Reactive Airway Disease (234 patients)
    (cough, age, gender and symptoms)
    PPA 92% (95%CI 88%-95%)
    NPA 89% (95%CI 84%-93%)

    Lower Respiratory Tract Involvement (492 patients)
    (cough, age, gender and symptoms)
    PPA 90% (95%CI 87%-93%)
    NPA 92% (95%CI 89%-94%)
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.